Shelton Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,170
Closed -$151K 734
2025
Q1
$151K Hold
10,170
﹤0.01% 677
2024
Q4
$152K Sell
10,170
-735
-7% -$12K ﹤0.01% 709
2024
Q3
$209K Hold
10,905
0.01% 698
2024
Q2
$226K Sell
10,905
-726
-6% -$14.4K 0.01% 632
2024
Q1
$219K Sell
11,631
-895
-7% -$15.4K 0.01% 682
2023
Q4
$181K Buy
+12,526
New +$170K 0.01% 707
2021
Q4
Sell
-8,609
Closed -$282K 882
2021
Q3
$282K Sell
8,609
-894
-9% -$28.6K 0.01% 583
2021
Q2
$288K Buy
+9,503
New +$313K 0.01% 596

Other funds holding OGN

Shelton Capital Management's OGN Position: Q2 2025 in Review

Shelton Capital Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 10,170 shares — an estimated $151K sold.

Shelton Capital Management first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $288K in Q2 2021. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Shelton Capital Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Shelton Capital Management sold 10,170 Organon & Co shares in Q2 2025, an estimated $151K.
  • Shelton Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • Shelton Capital Management's Organon & Co position peaked at $288K in Q2 2021.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Shelton Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.